Phase II Imatinib + Hydroxyurea in Treatment of Patients With Recurrent/Progressive Grade II Low-Grade Glioma (LGG)
Clinical trial NCT00615927 · COMPLETED
Trial details
- NCT number
- NCT00615927
- Sponsor
- Duke University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-01
- Primary completion
- 2009-04-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.